Kamran Pooshang Bagheri

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Escherichia Coli

Multidrug Resistant

Bioinformatics Analysis

Gene Expression

Top Venues

Current protein & peptide science

Molecules (Basel, Switzerland)

Chemical biology & drug design

Transactions of the Royal Society of Tropical Medicine and Hygiene

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad Hosseininejad Chafi, Mohsen Eslamnezhad-Namin, Mansoureh Shahbazi Dastjerdeh, Mohammad Reza Zareinejad, Akbar Oghalaie, Kamran Pooshang Bagheri, Fatemeh Kazemi-Lomedasht, Gholamreza Karimi, Mehdi Razzaghi-Abyaneh, Sima Sadat Seyedjavadi, Mahdi Behdani
CTXP, The Major Cobra Toxin Peptide from Naja Naja Oxiana Venom; A Promising Target for Antivenom Agent Development. Current protein & peptide science 25 (6) (2024)
Mohammad Hosseininejad Chafi, Mohsen Eslamnezhad-Namin, Mansoureh Shahbazi Dastjerdeh, Mohammad Reza Zareinejad, Akbar Oghalaie, Kamran Pooshang Bagheri, Fatemeh Kazemi-Lomedasht, Gholamreza Karimi, Mehdi Razzaghi-Abyaneh, Sima Sadat Seyedjavadi, Mahdi Behdani
CTXP, The Major Cobra Toxin Peptide From Naja Naja Oxiana Venom; A Promising Target for Antivenom Agent Development. Current protein & peptide science (2024)
Mohammad Hosseininejad Chafi, Mohsen Eslamnezhad-Namin, Mansoureh Shahbazi Dastjerdeh, Mohammad Reza Zareinejad, Akbar Oghalaie, Kamran Pooshang Bagheri, Fatemeh Kazemi-Lomedasht, Gholamreza Karimi, Mehdi Razzaghi-Abyaneh, Sima Sadat Seyedjavadi, Mahdi Behdani
CTXP, The Major Cobra Toxin Peptide from Naja Naja Oxiana Venom; A Promising Target for Antivenom Agent Development. Current protein & peptide science 25 (6) (2024)
Mahsa Shadmani, Atefeh Ghasemnejad, Samira Bazmara, Kamran Pooshang Bagheri
Designing a Novel di-epitope Diphtheria Vaccine: A Rational Structural Immunoinformatics Approach. Current computer-aided drug design (2024)
Parisa Amiri, Mojdeh Hakemi-Vala, Ahmad Nazarian, Farnoosh Barneh, Kamran Pooshang Bagheri
In Silico and In vitro Assessment of Antibacterial Activity, LPS Binding Affinity, and Toxicity of the GKY25 Peptide. Current pharmaceutical design (2023)
Ali Rezaei, Saeme Asgari, Samira Komijani, Seyedeh Narjes Sadat, Jean Marc Sabatier, Davood Nasrabadi, Kamran Pooshang Bagheri, Delavar Shahbazzadeh, Mohammad Reza Akbari Eidgahi, Michel De Waard, Hasan Mirzahoseini
Discovery of Leptulipin, a New Anticancer Protein from theIranian Scorpion, Hemiscorpius lepturus . Molecules (Basel, Switzerland) 27 (7) (2022)
Reza Akbari, Mojdeh Hakemi Vala, Jean-Marc Sabatier, Kamran Pooshang Bagheri
Fast killing kinetics, significant therapeutic index, and high stability of melittin-derived antimicrobial peptide. Amino acids 54 (9) (2022)
Sedigheh Bagheri-Ziari, Delavar Shahbazzadeh, Soroush Sardari, Jean-Marc Sabatier, Kamran Pooshang Bagheri
Discovery of a New Analgesic Peptide, Leptucin, from the Iranian Scorpion, Hemiscorpius lepturus. Molecules (Basel, Switzerland) 26 (9) (2021)
Parviz Parvizi, Massoud Amanlou, Kamran Pooshang Bagheri, Paul Donald Ready, Sahar Ebrahimi, Hamid Shahbaz Mohammadi, Seyedeh Maryam Ghafari, Parviz Parvizi
Cloning, high-level gene expression and bioinformatics analysis of SP15 and LeIF from Leishmania major and Iranian Phlebotomus papatasi saliva as single and novel fusion proteins: a potential vaccine candidate against leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 115 (6) (2021)
Abouzar Soleimani Moez, Reza H Sajedi, Kamran Pooshang Bagheri, Jean Marc Sabatier, Delavar Shahbazzadeh
Novel Mutant Phospholipase D from Hemiscorpius lepturus Acts as A Highly Immunogen in BALB/c Mice Against the Lethality of Scorpion Venom. Molecules (Basel, Switzerland) 25 (7) (2020)
Hossein Aghazadeh, Hamed Memariani, Reza Ranjbar, Kamran Pooshang Bagheri
The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli. Chemical biology & drug design 93 (1) (2018)